DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Velneperit
Velneperit
Перспективи Фармакологічного Застосування Нейропептиду Y Та Його Фрагментів
Neuropeptide Y6 Receptors Are Critical Regulators of Energy Metabolism
(12) Patent Application Publication (10) Pub. No.: US 2012/0022039 A1 Schwink Et Al
Stems for Nonproprietary Drug Names
Instituto Superior De Ciências Da Saúde Egas Moniz
GPCR/G Protein
Download Product Insert (PDF)
(12) Patent Application Publication (10) Pub. No.: US 2015/0202317 A1 Rau Et Al
Orally Active Compound Library (96-Well)
Antiobesity Pharmacotherapy: New Drugs and Emerging Targets
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NPY Receptors As Potential Targets for Anti-‐Obesity Drug Development
To Investigate the Physiological Role of Arcuate Nucleus Cocaine- and Amphetamine- Regulated Transcript in Energy Homeostasis
Ep 2838891 B1
Tratamiento Farmacológico Contra La Obesidad
(10) Patent No.: US 9670261 B2
Neurological - Molecular Interface in Food Intake and Metabolism in Birds And
(12) United States Patent (10) Patent No.: US 9,694,053 B2 Haack Et Al
Top View
HOULUTUULLITTURUS009789165B2 (12 ) United States Patent (10 ) Patent No
Neuropeptide Y Receptor NPY Receptor
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
Pharmaabkommen A1 E
Mecanismos Celulares De Acción De Los Agonistas De Los Receptores De GLP-1 Antonio Niño
New and Emerging Drug Molecules Against Obesity
Effectiveness of Pharmacotherapy in Obesity Treatment ------Targeting the Central Nervous System and Peripheral Hormones
Possiamo Puntare Ancora Di Più Sul Calo Ponderale?
Bioactive Compound Library Plus (96-Well)
Shionogi Announces Positive Top-Line Efficacy Results from Year-Long
Relationship Between Serum Leptin Level and Obesity in Type 2 Diabetic and Non-Diabetic Female Nigerians at Ile-Ife, South Western Nigeria
New Anti-Obesity Drugs on the Horizon
INN-Nimet 1 27.11.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Drug Repurposing Compound Library Plus (96-Well)
The Role of Forebrain Neuropeptide Y in the Regulation And
Current and Future Drug Targets in Weight Management
(51) International Patent Classification: A61K 31/506 (2006.01) C07F 9/09 (2006.01) C07D 487/04 (2006.01) AO, AT, AU, AZ, BA, BB
Tepzz 5 58¥Zb T
Cell-Type Specific Interrogation of Cea Drd2 Neurons to Identify Targets for 2 Pharmacological Modulation of Fear Extinction
Obesity Drug Update: the Lost Decade?
Drug Repurposing Compound Library (96-Well)
Endocrinology
WO 2017/106175 A2 22 June 2017 (22.06.2017) W P O P C T
(12) United States Patent (10) Patent No.: US 8,841,290 B2 Schwink Et Al
Aisa Fornovi Justo Tesis Doctoral.Pdf
Drug Interventions for the Treatment of Obesity in Children and Adolescents (Review)
Endocrinology Compound Library (96-Well)
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri